Trump should keep the ‘zero-to-zero’ tariff policy on pharmaceuticals 

President Trump has imposed a 15 percent tariff connected astir items successful a commercialized statement with the European Union, with pharmaceuticals excluded pending an ongoing U.S. investigation, but Trump is inactive pushing for tariffs connected drugs to promote onshoring and bring much U.S. pharmaceutical manufacturing jobs to the U.S.